Skip to content

Ayurvedic management of childhood Bronchial Asthma

Clinical study on Draksha Haritakyadi Avaleha (syrup) in the management of Tamaka Shwasa (Bronchial Asthma) in children-an open labelled randomized trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046273
Enrollment
60
Registered
2022-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Sponsors

UPGIASR DSRRAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pre diagnosed and confirmed patients of Tamaka Shwasa

Exclusion criteria

Exclusion criteria: 1.Child below 05 year & above 12 years of age will be excluded from present study. 2.Patients suffering from chronic respiratory disorders like pulmonary tuberculosis, chronic lung disease, pulmonary edema, branchiogenic carcinoma will be excluded from present study. 3.Patient suffering from cardiac disease, GIT disease, genitourinary disease, metabolic disorders like diabetes mellitus and behavioral disorders etc. will be excluded from study.

Design outcomes

Primary

MeasureTime frame
Effect of Draksha Haritakyadi Avaleha Syrup) in the management of Tamaka Shwasa in childrenTimepoint: 45 days

Secondary

MeasureTime frame
To establishment a safe and cost effective medicine for the Treatment of Bala Tamaka ShwasaTimepoint: 45 Days

Countries

India

Contacts

Public ContactDr Sahun Khan

DSRRAU

drppvyas@gmail.com9660057022

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026